Evidence map›Paper›PMID 33322473›Full record

ArticleCancers2020

Development of a Prognostic Tool to Guide the Decision to Extend Adjuvant Aromatase Inhibitors for up to Ten Years in Postmenopausal Early Breast Cancer Patients.

Camille Moreau-Bachelard, Loïc Campion, Marie Robert, Olivier Kerdraon, Céline Renaudeau, Maud Aumont, Jean-Marc Classe, Mario Campone, Jean-Sébastien Frénel

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Camille Moreau-BachelardDepartment of Medical Oncology, Institut de Cancérologie de l'Ouest, Boulevard Professeur Jacques Monod, 44800 Saint-Herblain, France.
Loïc CampionDepartment of Biometrics, Institut de Cancérologie de l'Ouest, Boulevard Professeur Jacques Monod, 44800 Saint-Herblain, France.ORCID 0000-0003-4903-0908
Marie RobertDepartment of Medical Oncology, Institut de Cancérologie de l'Ouest, Boulevard Professeur Jacques Monod, 44800 Saint-Herblain, France.
Olivier KerdraonDepartment of Pathology, Institut de Cancérologie de l'Ouest, Boulevard Professeur Jacques Monod, 44800 Saint-Herblain, France.
Céline RenaudeauDepartment of Surgery, Institut de Cancérologie de l'Ouest, Boulevard Professeur Jacques Monod, 44800 Saint-Herblain, France.
Maud AumontDepartment of Radiation Oncology, Institut de Cancérologie de l'Ouest, Boulevard Professeur Jacques Monod, 44800 Saint-Herblain, France.
Jean-Marc ClasseDepartment of Surgery, Institut de Cancérologie de l'Ouest, Boulevard Professeur Jacques Monod, 44800 Saint-Herblain, France.
Mario CamponeDepartment of Medical Oncology, Institut de Cancérologie de l'Ouest, Boulevard Professeur Jacques Monod, 44800 Saint-Herblain, France.
Jean-Sébastien FrénelDepartment of Medical Oncology, Institut de Cancérologie de l'Ouest, Boulevard Professeur Jacques Monod, 44800 Saint-Herblain, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

early breast cancerhormone receptorlate recurrencepositive

Identifiers

PMID33322473
PMCPMC7763581

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.